This analysis investigates whether some companies may be negatively affecting their overall commercial success by aiming to maintain steady earnings per share growth and/or a target ratio of R&D spending to sales.

中文翻译：

---

在生物制药研发上花费的正确金额是多少？

该分析调查了一些公司是否旨在维持稳定的每股收益增长和/或R＆D支出与销售的目标比率，是否会对他们的整体商业成功产生负面影响。